207 completed. 207 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 207 | Completed 207 |
Follow Anemia: new trials by email Literature Review of Anemia trials Research Report on Anemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Maternal Fatigue After Postpartum Anemia Treatment With Intravenous Ferric Carboxymaltose and Oral Iron Therapy INTRAVENOUS FERRIC CARBOXYMALTOSE, oral iron therapy - Postpartum Fatigue, Iron Deficiency Anemia | Phase 4 | Completed | Pakistan Air Force (PAF) Hospital Islamabad | 134 | 2026-04-20 | 2026-10-19 |
| Effects of Hydroxyurea and Metformin in Transfusion Dependent Beta-Thalassemia Tablet Metformin (Group A), Tablet Hydroxyurea (Group B) - Transfusion Dependent Beta-thalassemia | Phase 4 | Completed | Bahria University | 96 | 2024-09-16 | 2026-04-28 |
| Optimizing Dosing Strategies in Oral Iron Supplementation Tardyferon - Iron Deficiencies, Iron Deficiency Anemia | Phase 4 | Completed | Luzerner Kantonsspital | 29 | 2024-03-01 | 2026-01-07 |
| Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women Iron Carboxymaltose, Iron Sucrose Injection - Iron Deficiency Anemia (IDA), Pregnancy | Phase 4 | Completed | CMH Multan Institute of Medical Sciences | 60 | 2024-02-01 | 2025-04-06 |
| The Effect of Preoperative Ferric Carboxymaltose Administration on Mortality in Geriatric Hip Fractures Ferric carboxymaltose - Hip Fractures, Anemia | Phase 4 | Completed | Istanbul University | 209 | 2023-10-10 | 2025-03-26 |
| CsA+ATG+AVA vs. CsA+AVA for the Treatment of Newly-diagnosed SAA in the Elderly Ciclosporin, Avatrombopag, Anti-Human Thymocyte Immunoglobulin, Rabbit - Aplastic Anemia | Phase 4 | Completed | Peking Union Medical College Hospital | 86 | 2023-09-15 | 2025-04-30 |
| A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease Daprodustat - Anemia, Renal Insufficiency, Chronic | Phase 4 | Completed | USRC Kidney Research | 161 | 2023-07-01 | 2024-05-24 |
| Preoperative Monoferric for Abdominal Surgery Monoferric - Anemia, Surgery | Phase 4 | Completed | Brigham and Women's Hospital | 37 | 2023-04-18 | 2026-08-26 |
| ORal IrON Supplementation with Ferric Maltol in Treating Iron Deficiency and Anaemia in Patients with Heart Failure (ORION-HF) Ferric maltol 30 mg (Feraccru®) - Heart Failure, Left-sided, Anemia, Iron Deficiency | Phase 4 | Completed | Hannover Medical School | 50 | 2023-02-21 | 2025-03-07 |
| South African Paediatric Surgical Outcomes Study 2 Ferrous gluconate syrup or ferrous fumarate/folic acid tablets - Paediatric Surgery, Anaemia | Phase 4 | Completed | University of Cape Town | 755 | 2023-02-09 | 2025-09-18 |
| Use of Tranexamic Acid After Vaginal Delivery with Episiotomy a RCT Placebo Control Trail Tranexamic acid, Placebo - Episiotomy Wound, Anemia | Phase 4 | Completed | Assuta Ashdod Hospital | 150 | 2022-07-25 | 2024-12-05 |
| Glutamine Role in Preventing Vaso-occlusive Crisis Among SCD Patients L-Glutamine, Oral Powder for Reconstitution, Standard of care - Sickle Cell Disease | Phase 4 | Completed | Ain Shams University | 60 | 2022-01-04 | 2024-01-09 |
| Ferric Carboxymaltose With or Without Phosphate Substitution for the Treatment of Iron Deficiency or Iron Deficiency Anemia Verum, Placebo - Anemia, Iron-deficiency | Phase 4 | Completed | Donat R. Spahn | 92 | 2021-11-11 | 2023-05-24 |
| Study of Roxadustat's Effect on Anemia in Patients With Diabetic Kidney Disease Roxadustat - Diabetic Kidney Disease, Anemia | Phase 4 | Completed | Second Xiangya Hospital of Central South University | 124 | 2021-11-02 | 2026-01-26 |
| Intravenous Iron vs. Oral Iron Supplementation for Postpartum Anemia Ferrous sulfate, Iron dextran - Anemia, Iron Deficiency, Delivery Complication | Phase 4 | Completed | The University of Texas Medical Branch, Galveston | 40 | 2021-10-07 | 2023-08-29 |
| Trial to Describe the Safety, Tolerability, and Immunogenicity of Trumenba When Administered to Immunocompromised Participants ≥10 Years of Age Trumenba - Meningococcal Vaccine | Phase 4 | Completed | Pfizer | 53 | 2021-08-18 | 2024-10-16 |
| An Indian Multi-centric Phase IV Study to Assess the Safety of Crizanlizumab in Sickle Cell Disease Patients crizanlizumab - Sickle Cell Disease (SCD) | Phase 4 | Completed | Novartis Pharmaceuticals | 140 | 2021-07-14 | 2025-09-26 |
| Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants Ferric Citrate 1 gram Oral Tablet, Standard of care phosphate-lowering therapy - Hyperphosphatemia, Anemia, Iron Deficiency | Phase 4 | Completed | USRC Kidney Research | 214 | 2021-06-29 | 2022-11-07 |
| A Clinical Trial Assessing the Efficacy of Intravenous Iron for the Treatment of Anemia Following Cardiac Surgery Ferric Derisomaltose, Ferrous sulfate, normal saline - Anemia Postoperative | Phase 4 | Completed | Michael Kremke | 110 | 2021-05-21 | 2023-06-28 |
| Ravulizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Currently Treated With High-Dose Eculizumab Eculizumab, Ravulizumab - Paroxysmal Nocturnal Hemoglobinuria | Phase 4 | Completed | Alexion Pharmaceuticals, Inc. | 18 | 2021-04-14 | 2024-09-05 |
Showing 20 of 207. Sign in to see all of them.
Anemia, Iron-Deficiency (47) · Renal Insufficiency, Chronic (20) · Iron Deficiencies (18) · Anemia, Sickle Cell (17) · Kidney Failure, Chronic (12) · beta-Thalassemia (11) · Thalassemia (10) · Iron Overload (9) · Myelodysplastic Syndromes (7) · Neoplasms (7) · Anemia, Aplastic (6) · Hepatitis C (6) · Kidney Diseases (6) · Malaria (6)
Hemic and Lymphatic Diseases (207) · Hematologic Diseases (205) · Nutritional and Metabolic Diseases (72) · Metabolic Diseases (69) · Iron Metabolism Disorders (65) · Pathological Conditions, Signs and Symptoms (57) · Urogenital Diseases (51) · Female Urogenital Diseases and Pregnancy Complications (49) · Anemia, Hypochromic (47) · Pathologic Processes (47) · Anemia, Hemolytic (44) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (43) · Genetic Diseases, Inborn (42) · Female Urogenital Diseases (41)
ferric carboxymaltose (20) · Darbepoetin alfa (15) · epoetin beta (15) · Epoetin Alfa (14) · ferrous sulfate (13) · continuous erythropoietin receptor activator (11) · Ferric Oxide, Saccharated (9) · ferric gluconate (8) · Deferasirox (7) · Iron-Dextran Complex (7) · Saline Solution (7) · Cyclosporine (5) · Ribavirin (5) · Sucrose (5) · Hydroxyurea (4)
Hoffmann-La Roche (17) · Amgen (10) · Novartis Pharmaceuticals (9) · Watson Pharmaceuticals (7) · Ain Shams University (4) · Assiut University (3) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (3) · University of Zurich (3) · Alexion Pharmaceuticals, Inc. (2) · American Regent, Inc. (2) · Bing Han (2) · Duke University (2) · Fakultas Kedokteran Universitas Indonesia (2) · Federico II University (2) · Imperial College London (2)
United States (40) · Egypt (14) · China (12) · United Kingdom (8) · Germany (7) · Switzerland (7) · Australia (6) · France (6) · India (6) · Italy (6) · Spain (6) · Pakistan (5) · Canada (4) · Argentina (3) · Denmark (3)
Adel R. Rizkala, Pharm.D., MS (2) · Fatma SE Ebeid, MD (2) · Harry Tagbor, DrPH (2) · Abdel-Latif G. El-Kholy, Ass. Prof. (1) · Adel R Rizkala, PharmD, MS (1) · Ahmed Gaber Ahmed (1)
PMID 36791280, PMID 18328118, PMID 34932836, PMID 41114449, PMID 18828899, PMID 19208097, PMID 24363761, PMID 26504182, PMID 27881371, PMID 14616423, PMID 15953714, PMID 16177289, PMID 16273116, PMID 16520948, PMID 16614237, PMID 16737942, PMID 16977654, PMID 17035697, PMID 17267740, PMID 17296819, PMID 17396118, PMID 17400086, PMID 17522247, PMID 17622274, PMID 17694552, PMID 17962803, PMID 18008242, PMID 18067679, PMID 18216316, PMID 18284320, PMID 18343652, PMID 18565240, PMID 18632499, PMID 19034302, PMID 19075138, PMID 19149890, PMID 19236376, PMID 19407319, PMID 19724055, PMID 19848610, PMID 19904293, PMID 20124051, PMID 20147465, PMID 20163377, PMID 20715601, PMID 20819898, PMID 2096501, PMID 21162725, PMID 21240875, PMID 21388319
2009 (2), 2015 (1), 2016 (1), 2018 (1), 2019 (1), 2023 (1), P30AI060354 (1), R24TW007988 (1)